SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000882104-19-000059
Filing Date
2019-05-31
Accepted
2019-05-31 16:24:07
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a20190531s3doc.htm S-3 281056
2 FORM OF DEBT SECURITIES INDENTURE debtsecuritiesindenture.htm EX-4.6 413115
3 OPINION OF GIBSON, DUNN & CRUTCHER LLP legalopinion.htm EX-5.1 45903
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP consentofauditor.htm EX-23.1 2859
5 pdllogo01.jpg GRAPHIC 123123
  Complete submission text file 0000882104-19-000059.txt   913423
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231870 | Film No.: 19870779
SIC: 2836 Biological Products, (No Diagnostic Substances)